Cargando…
Viral gene delivery vectors: the next generation medicines for immune-related diseases
Viruses have evolved to efficiently express their genes in host cells, which makes them ideally suited as gene delivery vectors for gene and immunotherapies. Replication competent (RC) viral vectors encoding foreign or self-proteins induce strong T-cell responses that can be used for the development...
Autores principales: | De Haan, Peter, Van Diemen, Ferdy R., Toscano, Miguel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872028/ https://www.ncbi.nlm.nih.gov/pubmed/32412865 http://dx.doi.org/10.1080/21645515.2020.1757989 |
Ejemplares similares
-
Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies
por: Toscano, Miguel G., et al.
Publicado: (2017) -
Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy
por: Wahane, Aniket, et al.
Publicado: (2020) -
Next-Generation Gene Therapy for Parkinson’s Disease Using Engineered Viral Vectors
por: Björklund, Tomas, et al.
Publicado: (2021) -
Improved functionality and potency of next generation BinMLV viral vectors toward safer gene therapy
por: Van Looveren, Dominique, et al.
Publicado: (2021) -
Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy
por: Ren, Duohao, et al.
Publicado: (2022)